Abstract
Background. A 19-year-old girl was diagnosed with systemic lupus erythematosus, based on findings of arthritis, malar rash, positive antinuclear antibody test and high levels of antibodies to double-stranded DNA. Two months after diagnosis, the patient presented with a sudden drop in blood hemoglobin level. Several days later, she developed bloody sputum, rapidly progressive dyspnea and hypoxemia. High-resolution CT showed diffuse alveolar infiltrates in both lung fields.
Investigations. Physical examination, complete blood count, erythrocyte sedimentation rate, urinalysis, 24-h urine protein excretion, fecal occult blood test, d-dimer test, acid hemolysis test, activated partial thromboplastin time and prothrombin time, direct and indirect Coombs tests, bone marrow smear, arterial blood gas, sputum smear and culture, and high-resolution CT scan of the chest.
Diagnosis. Diffuse alveolar hemorrhage associated with systemic lupus erythematosus.
Management. The patient did not respond to pulsed intravenous methylprednisolone (two courses of 500 mg per day for 3 days) and intravenous immunoglobulin (20 g per day for 5 days). The patient was referred to a specialist treatment center for allogenic transplantation using umbilical-cord-derived mesenchymal stem cells. She underwent transplantation with an infusion of 8 × 107 mesenchymal stem cells. After showing dramatic improvements in her clinical condition, oxygenation level, radiographic and hematological status, the patient was discharged from hospital approximately 5 weeks after undergoing transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Santos-Ocampo, A. S., Mandell, B. F. & Fessler, B. J. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 118, 1083–1090 (2000).
Zamora, M. R. et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Medicine 76, 192–202 (1997).
Guleria, R. & Pangtey, G. Lung in SLE. Indian Journal of Rheumatology 4, 131–132 (2007).
Green, R. J. et al. Pulmonary capillaritis and alveolar hemorrhage. Chest 110, 1305–1316 (1996).
Todd, D. J. & Costenbader, K. H. Dyspnoea in a young woman with active systemic lupus erythematosus. Lupus 18, 777–784 (2009).
Cañas, C. et al. Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus. Clin. Rheumatol. 26, 1947–1949 (2007).
Chang, M. Y. et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan. Ren. Fail. 24, 791–802 (2002).
Wu, C. Y. et al. Severe pulmonary hemorrhage as the initial presentation in systemic lupus erythematosus with active nephritis. Lupus 10, 879–882 (2001).
Santos, B. H. et al. Pulmonary hemorrhage as a manifestation of systemic lupus erythematosus. Rev. Hosp. Clin. Fac. Med. S. Paulo 59, 47–50 (2004).
Zhang, B. et al. Mesenchymal stem cells induce mature dendritic cells into a novel jagged-2-dependent regulatory dendritic cell population. Blood 113, 46–57 (2009).
Nauta, A. J. & Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 15, 3499–3506 (2007).
Prigione, I. et al. Reciprocal interactions between human mesenchymal stem cells and γδ T cells or invariant natural killer T cells. Stem Cells 27, 693–702 (2009).
Sotiropoulou, P. A. et al. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24, 74–85 (2006).
Le Blanc, K. et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579–1586 (2008).
Sun, L. Y. et al. Abnormality of bone marrow-derived stem cell in patients with systemic lupus erythematosus. Lupus 16, 121–128 (2007).
Zhou, K. X. et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell. Mol. Immunol. 5, 417–424 (2008).
Sun, L. Y. et al. Mesenchymal stem cell transplantation reverses multi-organ dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27, 1421–1432 (2009).
Zhao, F. et al. Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant. Proc. 40, 1700–1705 (2008).
Gupta, N. et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 179, 1855–1863 (2007).
Weiss, M. L. & Troyer, D. L. Stem cells in the umbilical cord. Stem Cell Rev. 2, 155–162 (2006).
Lu, L. L. et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Hematologica 91, 1017–1026 (2006).
Valencia, X. et al. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178, 2579–2588 (2007).
Nalbandian, A., Crispín, J. C. & Tsokos, G. C. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin. Exp. Immunol. 157, 209–215 (2009).
Berger, M. J. et al. Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy 8, 480–487 (2006).
Acknowledgements
The authors are grateful to the patient's family for granting permission to write this case report. They thank Dr. Xiang Hu and Shengqin Ye (Jiangsu Stem Cell Bank, Jiangsu, China) for providing the MSCs. They thank Dr. Gary S. Gilkeson (Department of Rheumatology, Medical University of South Carolina, Charleston, SC, USA) for his critical review of the manuscript. This work was supported by grants from the National Natural Science Foundation of China (No. 30772014 and No. 30972736), Jiangsu Province 135 Talent Foundation (RC2007002), Jiangsu Province Natural Science Foundation (No. 09KJB320010), Jiangsu Province Science-Technology Achievement Transforming Foundation (BA2009124), Jiangsu Province “Six Summit Talent” Foundation and Nanjing Health Bureau Young Scientists Launching Project (QYK09174).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Liang, J., Gu, F., Wang, H. et al. Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 6, 486–489 (2010). https://doi.org/10.1038/nrrheum.2010.80
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2010.80
This article is cited by
-
Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series
Pediatric Rheumatology (2021)
-
Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus
Archivum Immunologiae et Therapiae Experimentalis (2021)
-
Mesenchymale Stammzelltherapie bei Autoimmunerkrankungen
Zeitschrift für Rheumatologie (2020)
-
Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
Cellular and Molecular Life Sciences (2020)
-
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Nature Reviews Nephrology (2018)